Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2003
12/23/2003US6667320 For therapy of infalmmation; asthma, cancer, arthritis, multiple sclerosis; prophylaxis of infection of target cells by a human immunodeficiency virus (HIV)
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667303 Aryl substituted 1,4-diazepanes and method of use thereof
12/23/2003US6667302 Heterocyclic topoisomerase poisons
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/18/2003WO2003105538A1 Electroluminescent device
12/18/2003WO2003104333A1 Yellow anionic disazo dyes
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104193A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103772A1 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
12/18/2003WO2003103679A1 Use of devazepide in combination with an opioid analgesic for potentiating the effect of the analgesic
12/18/2003WO2003103664A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103598A2 Amidine derivatives for treating amyloidosis
12/18/2003WO2003103398A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003024401A3 Piperizinones as modulators of chemokine receptor activity
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003US20030232998 A 4-imidazolines carboxyl acids or esters as a potent non-steroidal antiinflammatory agents, microbiocides, bactericides, antitumor agents; chemical intermediates
12/18/2003US20030232988 Methods for making bis-heterocyclic alkaloids
12/18/2003US20030232870 Multi-substituted imidazolines and method of use thereof
12/18/2003US20030232869 N3 alkylated benzimidazole derivatives as MEK inhibitors
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/18/2003US20030232849 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/18/2003US20030232848 Pyrazole compositions
12/18/2003US20030232843 (1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
12/18/2003US20030232831 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/18/2003US20030232828 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
12/18/2003US20030232816 Benzimidazole derivatives
12/18/2003US20030232807 Dietetic agents
12/18/2003CA2488798A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488602A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488493A1 Amidine derivatives for treating amyloidosis
12/18/2003CA2488406A1 Yellow anionic disazo dyes
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2487977A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2487430A1 Electroluminescent device
12/18/2003CA2485725A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/17/2003EP1371650A1 Activator for peroxisome proliferator-activated receptor
12/17/2003EP1370682A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370557A1 Benzimidazole anti-inflammatory compounds
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370555A1 Compounds derived from oxindoles and the use thereof in cancerology
12/17/2003EP1370554A1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370250A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003EP0871625B1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1462193A Oral preparations
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/16/2003US6664398 Derivatives of erythromycin, their preparation process and their use as medicaments
12/16/2003US6664395 Benzotriazole compoundsn are the potent inhibitors of MAP kinases, preferably p38 kinase. They are useful for treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion, ischemia
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664249 Bicyclic vasopressin agonists
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003CA2178272C Antiviral monocyclic polyamines
12/16/2003CA2099822C Tri-higher alkyl tin azide and its use
12/11/2003WO2003101985A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003WO2003101972A1 Copper-catalysed ligation of azides and acetylenes
12/11/2003WO2003101969A1 Multi-substituded imidazolines and method of use thereof
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101962A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003WO2003101961A1 Novel substituted indoles
12/11/2003WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
12/11/2003WO2003101956A1 Pharmaceutical combination
12/11/2003WO2003101954A2 Nf-kb inhibitors and uses thereof
12/11/2003WO2003101444A1 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003043632A3 Use of bisindolmaleimide and gemcitabine for the treatment of cancer
12/11/2003WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer
12/11/2003WO2003024926A3 Methods and compositions of novel triazine compounds
12/11/2003WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003US20030229229 Anticancer agents; kinase inhibitors; antiallergens; autoimmune disease; rheumatic diseases; skin disorders
12/11/2003US20030229133 Amidine inhibitors of serine proteases
12/11/2003US20030229123 2-(Substituted-phenyl)amino-imidazoline derivatives
12/11/2003US20030229120 Zinc binding ligand; sustained release of insulin
1 ... 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 ... 626